Skip to main content
. 2020 Mar 3;66(1):67–72. doi: 10.5606/tftrd.2020.2928

Table 3. Clinical findings of the patient and control groups.

    Patient group (n=40)     Control group (n=40)  
  n % Median Min-Max n % Median Min-Max p
Previous bone fracture 2 5.0     2 5.0     1.000
Musculoskeletal pain 38 95.0     25 62.5     <0.001
Proximal muscle weakness 9 22.5     1 2.5     0.007
Abnormal walking gait 3 7.5     1 2.5     0.615
Periarticular sensitivity 26 5.0     9 22.5     <0.001
Visual analog scale score     6 0-10     5 0-8 0.004
Beck Depression Inventory score                 0.375
Normal 12 30.0     19 47.5      
Mild 13 32.5     11 27.5      
Moderate 12 30.0     9 22.5      
Severe 3 7.5     1 2.5      
Short Form 36                  
Physical component summary     37 20-57     32 16-61 0.419
Mental component summary     42 14-56     44 25-59 0.633
Min: Minimum; Max: Maximum; Patient group: Serum 25(OH)D3 level <25 ng/mL; Control group: Serum 25(OH)D3 level ≥25 ng/mL.